EUVIMEDEUVIMED entdecken
Crossref

Formulation Development and Physicochemical Characterization of Deucravacitinib–Cyclodextrin Inclusion Complexes

Mrynal Chamoli, Sheshadri S N, Yogesh Joshi, Azhar Khan, Himangshu Jyoti Sharma, Jay Upadhyay, Deepika Sharma, Boi Basanta Kumar Reddy

International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)

DOI: 10.25258/ijddt.16.43s.76 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Mrynal Chamoli und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Deucravacitinib (DEU) exhibits poor aqueous solubility, which significantly limits its dissolution rate and oral bioavailability. This study aimed to enhance the solubility and in vitro dissolution profile of DEU through the formation of solid inclusion complexes using hydroxypropyl-β-cyclodextrin (HP-β-CD) and sulfobutylether-βcyclodextrin (SBE-β-CD).

Methods

Binary systems of DEU with the respective cyclodextrins were prepared using physical mixing (PM), the kneading method (KM), and the lyophilization method (LM). The solid-state characteristics and surface morphology of the pure drug, physical mixtures, and inclusion complexes were analyzed using scanning electron microscopy (SEM). In vitro dissolution studies were conducted to evaluate cumulative drug release, with emphasis on the initial release at 15 minutes (Q₁₅).

Results

SEM analysis revealed a clear morphological transformation. Pure DEU exhibited well-defined crystalline structures, whereas the inclusion complexes particularly those prepared by lyophilization displayed a highly porous and amorphous morphology, indicating successful complex formation. Dissolution studies demonstrated a substantial enhancement in drug release. Pure DEU showed a low Q₁₅ of 12.5%, while the lyophilized DEU/SBE-β-CD complex exhibited the highest release, achieving a Q₁₅ of 89.3%, significantly surpassing both physical mixtures and kneaded formulations.

Conclusion

The formation of DEU–cyclodextrin inclusion complexes, especially with SBE-β-CD via lyophilization, effectively induces amorphization and markedly improves the dissolution rate. This strategy represents a promising and efficient approach to overcome the solubility limitations of Deucravacitinib and to enhance its oral bioavailability.

Zitieren

APA

Chamoli, M., N, S. S., Joshi, Y., Khan, A., Sharma, H. J., Upadhyay, J., Sharma, D., & Reddy, B. B. K. (2026). Formulation Development and Physicochemical Characterization of Deucravacitinib–Cyclodextrin Inclusion Complexes. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.76

Vancouver

Chamoli M, N SS, Joshi Y, Khan A, Sharma HJ, Upadhyay J, et al. Formulation Development and Physicochemical Characterization of Deucravacitinib–Cyclodextrin Inclusion Complexes. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.76

BibTeX
@article{Chamoli2026,
  author = {Chamoli, Mrynal and N, Sheshadri S and Joshi, Yogesh and Khan, Azhar and Sharma, Himangshu Jyoti and Upadhyay, Jay and Sharma, Deepika and Reddy, Boi Basanta Kumar},
  title = {Formulation Development and Physicochemical Characterization of Deucravacitinib–Cyclodextrin Inclusion Complexes},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {43s},
  doi = {10.25258/ijddt.16.43s.76}
}
Kostenlos starten →